UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review

Cancer letters, 2018-02, Vol.414, p.166-173

2018

Volltextzugriff (PDF)

Radiotherapy combined with immunotherapy: the dawn of cancer treatment

Signal transduction and targeted therapy, 2022-07, Vol.7 (1), p.258-258, Article 258

2022

Volltextzugriff (PDF)

Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy

Cancer treatment reviews, 2015-12, Vol.41 (10), p.868-876

2015

Volltextzugriff (PDF)

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Journal of experimental & clinical cancer research, 2019-02, Vol.38 (1), p.87-13, Article 87

2019

Volltextzugriff (PDF)

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Journal of hematology and oncology, 2018-08, Vol.11 (1), p.104-104, Article 104

2018

Volltextzugriff (PDF)

Recent Development of pH-Responsive Polymers for Cancer Nanomedicine

Molecules (Basel, Switzerland), 2018-12, Vol.24 (1), p.4

2018

Volltextzugriff (PDF)

SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges

Journal of hematology and oncology, 2020-07, Vol.13 (1), p.105-17, Article 105

2020

Volltextzugriff (PDF)

Radiation recall pneumonitis induced by PD-1/PD-L1 blockades: mechanisms and therapeutic implications

BMC medicine, 2020-09, Vol.18 (1), p.275-8, Article 275

2020

Volltextzugriff (PDF)

The prognostic significance of PD-L1 expression in patients with glioma: A meta-analysis

Scientific reports, 2017-06, Vol.7 (1), p.4231-8, Article 4231

2017

Volltextzugriff (PDF)

The landscape of bispecific T cell engager in cancer treatment

Biomarker research, 2021-05, Vol.9 (1), p.1-23, Article 38

2021

Volltextzugriff (PDF)

Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis

PloS one, 2016-01, Vol.11 (1), p.e0146195-e0146195

2016

Volltextzugriff (PDF)

Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors

Frontiers in oncology, 2020-12, Vol.10, p.602762-602762

2020

Volltextzugriff (PDF)

Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC

Cancer letters, 2018-04, Vol.418, p.1-9

2018

Volltextzugriff (PDF)

Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy

Journal of hematology and oncology, 2017-04, Vol.10 (1), p.81-81, Article 81

2017

Volltextzugriff (PDF)

MiR‐216a‐3p inhibits colorectal cancer cell proliferation through direct targeting COX‐2 and ALOX5

Journal of cellular biochemistry, 2018-02, Vol.119 (2), p.1755-1766

2018

Volltextzugriff (PDF)

Looking for the Optimal PD-1/PD-L1 Inhibitor in Cancer Treatment: A Comparison in Basic Structure, Function, and Clinical Practice

Frontiers in immunology, 2020-05, Vol.11, p.1088

2020

Volltextzugriff (PDF)

Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients

BMC cancer, 2024-02, Vol.24 (1), p.197-197, Article 197

2024

Volltextzugriff (PDF)

A good start of immunotherapy in esophageal cancer

Cancer medicine (Malden, MA), 2019-08, Vol.8 (10), p.4519-4526

2019

Volltextzugriff (PDF)

PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges

Cancer letters, 2017-10, Vol.405, p.29-37

2017

Volltextzugriff (PDF)

Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors

Frontiers in oncology, 2022-03, Vol.12, p.837952

2022

Volltextzugriff (PDF)

Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer

Journal of hematology and oncology, 2019-06, Vol.12 (1), p.67-67, Article 67

2019

Volltextzugriff (PDF)

Distinguishing immune checkpoint inhibitor-related pneumonitis from radiation pneumonitis by CT radiomics features in non-small cell lung cancer

International immunopharmacology, 2024-02, Vol.128, p.111489-111489, Article 111489

2024

Volltextzugriff (PDF)

Proton beam therapy for cancer in the era of precision medicine

Journal of hematology and oncology, 2018-12, Vol.11 (1), p.136-136, Article 136

2018

Volltextzugriff (PDF)

Fucoidan Promotes Apoptosis and Inhibits EMT of Breast Cancer Cells

Biological and Pharmaceutical Bulletin, 2019/03/01, Vol.42(3), pp.442-447

2019

Volltextzugriff (PDF)

Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2

Biomedicine & pharmacotherapy, 2020-05, Vol.125, p.109964, Article 109964

2020

Volltextzugriff (PDF)

1 – 25 von 1.683

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.464)
Mit Volltextzugriff
(1.523)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review

Radiotherapy combined with immunotherapy: the dawn of cancer treatment

Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Recent Development of pH-Responsive Polymers for Cancer Nanomedicine

SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges

Radiation recall pneumonitis induced by PD-1/PD-L1 blockades: mechanisms and therapeutic implications

The prognostic significance of PD-L1 expression in patients with glioma: A meta-analysis

The landscape of bispecific T cell engager in cancer treatment

Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis

Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors

Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC

Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy

MiR‐216a‐3p inhibits colorectal cancer cell proliferation through direct targeting COX‐2 and ALOX5

Looking for the Optimal PD-1/PD-L1 Inhibitor in Cancer Treatment: A Comparison in Basic Structure, Function, and Clinical Practice

Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients

A good start of immunotherapy in esophageal cancer

PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges

Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors

Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer

Distinguishing immune checkpoint inhibitor-related pneumonitis from radiation pneumonitis by CT radiomics features in non-small cell lung cancer

Proton beam therapy for cancer in the era of precision medicine

Fucoidan Promotes Apoptosis and Inhibits EMT of Breast Cancer Cells

Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2

Aktive Filter

Suchergebnisse filtern